Table 4.
Adjusted prevalence of being at LDL goal for those on statins (N = 537), without (Model I) and with (Model II) adjustment for access/utilization.
| Model I | Model II | |||||||
|---|---|---|---|---|---|---|---|---|
| Social Risk Factor | AME | 95% CI | P | AME | 95% CI | P | ||
| Age group | ||||||||
| 35-44 | 5.12 | -17.93 | 28.17 | 0.66 | 4.26 | -18.14 | 26.66 | 0.71 |
| 45-54 | 13.19 | -4.48 | 30.85 | 0.14 | 11.59 | -5.69 | 28.87 | 0.19 |
| 55-64 | -5.49 | -19.88 | 8.89 | 0.45 | -4.63 | -16.30 | 7.04 | 0.44 |
| ≥ 65 (reference) | ||||||||
| Female | 14.07 | 8.95 | 19.20 | <0.01 | 13.93 | 8.39 | 19.46 | <0.01 |
| Race/Ethnicity | ||||||||
| White (reference) | ||||||||
| Black | -6.38 | -23.19 | 10.43 | 0.46 | -4.91 | -18.10 | 8.28 | 0.47 |
| Hispanic | -1.83 | -19.18 | 15.52 | 0.84 | -2.33 | -19.42 | 14.77 | 0.79 |
| Other | 3.70 | -27.17 | 34.58 | 0.81 | 1.63 | -25.83 | 29.10 | 0.91 |
| Federal Poverty Level (%) | ||||||||
| <100 (reference) | ||||||||
| 100-149 | 13.80 | -4.26 | 31.87 | 0.13 | 13.84 | -1.42 | 29.10 | 0.08 |
| 149-199 | 19.23 | -1.77 | 40.23 | 0.07 | 18.02 | 1.65 | 34.39 | 0.03 |
| 200-299 | 26.63 | 11.96 | 41.30 | <0.01 | 26.22 | 11.86 | 40.58 | <0.01 |
| 300-499 | 28.50 | 15.50 | 41.50 | <0.01 | 27.47 | 14.63 | 40.30 | <0.01 |
| ≥ 500 | 31.54 | 20.80 | 42.29 | <0.01 | 31.68 | 21.99 | 41.37 | <0.01 |
| Education (years) | ||||||||
| <12 (reference) | ||||||||
| 12 | -7.56 | -24.18 | 9.07 | 0.37 | -6.32 | -20.02 | 7.39 | 0.37 |
| >12 | -4.95 | -20.10 | 10.19 | 0.52 | -3.89 | -17.12 | 9.34 | 0.56 |
Notes: AME = adjusted average marginal effect, adjusted% difference from reference group; CI = confidence interval. Age group 21-35 omitted due to empty cells. All analyses adjusted for survey year. Model II also adjusted for insurance, preferred language, usual source of care, and visit number. Source: NHANES 1999-2006.